Invested in Her Campaign Extends Fundraising Deadline

Driven by ongoing support from their community, The Longevity Science Foundation is extending the deadline for the Invested in Her campaign to October 1, 2026, as they work toward a $250,000 fundraising target to support early-stage research into ovarian aging and menopause.

Hundreds of millions of women live longer than men yet spend more years in poor health. The biology driving this disparity is rooted in ovarian aging and the menopausal transition, and it remains one of the most underfunded areas in medicine. Invested in Her is raising $250,000 to fund the science that closes that gap, for mothers, daughters, and women everywhere.

Only 8.8% of NIH funding is directed to women’s health research, and only a fraction of that studies ovarian aging and the menopausal transition. The result is that a critical biological transition remains insufficiently studied, limiting prevention, early intervention, and targeted treatment.

The implications extend across women’s long-term health. Women live longer than men on average but spend more years in poor health, while the hormonal cascade associated with ovarian decline and menopause reverberates across major systems, including cardiometabolic, brain, and skeletal health. Closing the research gap is how we begin to close the health gap.

Funding the Full Picture

Through its scientific review process, the LSF has identified a portfolio of high-impact projects ready for immediate funding. Rather than funding isolated therapies alone, the LSF is targeting the full arc of women’s reproductive aging through three coordinated pillars: measurement, biological understanding, and early-stage intervention.

The work will support:

• Measurement: developing better ways to measure ovarian aging and the menopausal transition, because better measurement is the first step to better medicine.
• Biology: answering why women’s aging unfolds the way it does and improving our understanding of the mechanisms connecting reproductive aging to broader systemic decline.
• Intervention: advancing early-stage approaches that treat reproductive aging as modifiable, not inevitable.

Building Momentum Around Women’s Health

The campaign recently brought its community together at 7 World Trade Center in New York City for the Invested in Her event, uniting investors, clinicians, researchers, founders, philanthropists, advocates, and other leaders across healthcare and industry. Through personal stories, presentations, panel discussions, and networking, participants explored the challenges facing women’s health and the opportunities to create meaningful change.

Attendee feedback reinforced the need for action. When asked about the biggest barriers to progress in women’s health, healthcare system design and lack of research funding led the room. For the LSF, the answer is clear: it needs to continue doing its part in funding holistic women’s health research to create equitable solutions for every woman.

Invested in Her will continue building on this momentum through October 1, directing attention and funding toward research that can improve how women’s reproductive aging is measured, understood, and ultimately addressed. 100% of donations go directly to research, with no overhead deducted, and all eligible gifts are tax-deductible. Support Invested in Her and help fund the science that closes the gap in women’s health, menopause, and ovarian aging research.